Clinical Trial Update: Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women [Phase 3]

View source ↗

Summary

This document reports the completion and status of the STAR Phase 3 trial comparing tamoxifen and raloxifene for the prevention of breast cancer in postmenopaus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Raloxifene (raloxifene)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED